(Q34577016)

3 August 2017

1 reference

title

Prostatitis and chronic prostatitis/chronic pelvic pain syndrome (English)

1 reference

3 August 2017

0 references

Jonathan Bergman

1

1 reference

PubMed ID

17341178

3 August 2017

Scott I Zeitlin

series ordinal

2

1 reference

3 August 2017

1 March 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

301-307

1 reference

3 August 2017

3

1 reference

Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients

3 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

HOW COMMON IS PROSTATITIS? A NATIONAL SURVEY OF PHYSICIAN VISITS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Urinary symptomatology in younger men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prevalence, diagnosis and treatment of prostatitis in Italy: a prospective urology outpatient practice study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Circumcision and infectious diseases revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

NIH consensus definition and classification of prostatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis".

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Use of terazosin in prostatodynia and validation of a symptom score questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Diagnosing and treating chronic prostatitis: do urologists use the four-glass test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prostatitis, prostatosis, and prostatodynia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Diagnosis and treatment of 409 patients with prostatitis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prostatitis: myths and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prostatitis: evolving management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Questionnaire survey of urologists and primary care physicians' diagnostic and treatment practices for prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Role of ejaculation in the treatment of chronic non-bacterial prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Use of prostatic massage in combination with antibiotics in the treatment of chronic prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prostatic abscess: imaging with transrectal ultrasound. Case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Pseudodyssynergia (Contraction of the External Sphincter During Voiding) Misdiagnosed as Chronic Nonbacterial Prostatitis and the Role of Biofeedback as a Therapeutic Option

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

Prevalence of a Physician-Assigned Diagnosis of Prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.3.301

21 January 2018

Identifiers

DOI

10.1586/14737175.7.3.301

1 reference

3 August 2017

1 reference

PubMed ID

17341178